Task: Answer the multiple choice question.
Question: Which drug has a -5.174% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) CCCc1cc(-c2[nH]ncc2-c2ccc(C(=O)OCC)o2)c(O)cc1O
b.) COc1ccc(OC2CCN(S(=O)(=O)c3ccc(F)cc3)CC2)cc1
c.) OCC[NH+](CCO)CC(O)COc1ccc(Br)cc1.[Cl-]
Answer: c. OCC[NH+](CCO)CC(O)COc1ccc(Br)cc1.[Cl-]
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
OCC[NH+](CCO)CC(O)COc1ccc(Br)cc1.[Cl-]
OCC[NH+](CCO)CC(O)COc1ccc(Br)cc1.[Cl-]
[3-(4-bromophenoxy)-2-hydroxypropyl]-bis(2-hydroxyethyl)azanium;chloride